134 related articles for article (PubMed ID: 11097475)
21. [Prognostic implications of extra-hepatic clinical manifestations, autoimmunity and microscopic nail capillaroscopy in patients with primary biliary cirrhosis].
Marí-Alfonso B; Amengual-Guedan MJ; Vergara-Gómez M; Simeón-Aznar CP; Fonollosa-Plà V; Jove-Buxeda E; Oliva-Morera J; Tolosa-Vilella C
Med Clin (Barc); 2016 Jan; 146(1):8-15. PubMed ID: 25978920
[TBL] [Abstract][Full Text] [Related]
22. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
23. Systemic and local expression levels of TNF-like ligand 1A and its decoy receptor 3 are increased in primary biliary cirrhosis.
Aiba Y; Harada K; Komori A; Ito M; Shimoda S; Nakamura H; Nagaoka S; Abiru S; Migita K; Ishibashi H; Nakanuma Y; Nishida N; Kawashima M; Tokunaga K; Yatsuhashi H; Nakamura M
Liver Int; 2014 May; 34(5):679-88. PubMed ID: 24016146
[TBL] [Abstract][Full Text] [Related]
24. Possible contribution of microchimerism to the pathogenesis of Sjögren's syndrome.
Endo Y; Negishi I; Ishikawa O
Rheumatology (Oxford); 2002 May; 41(5):490-5. PubMed ID: 12011370
[TBL] [Abstract][Full Text] [Related]
25. Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis.
Granito A; Muratori P; Muratori L; Pappas G; Cassani F; Worthington J; Ferri S; Quarneti C; Cipriano V; de Molo C; Lenzi M; Chapman RW; Bianchi FB
Aliment Pharmacol Ther; 2007 Sep; 26(6):831-8. PubMed ID: 17767467
[TBL] [Abstract][Full Text] [Related]
26. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis.
Nakamura M; Kondo H; Mori T; Komori A; Matsuyama M; Ito M; Takii Y; Koyabu M; Yokoyama T; Migita K; Daikoku M; Abiru S; Yatsuhashi H; Takezaki E; Masaki N; Sugi K; Honda K; Adachi H; Nishi H; Watanabe Y; Nakamura Y; Shimada M; Komatsu T; Saito A; Saoshiro T; Harada H; Sodeyama T; Hayashi S; Masumoto A; Sando T; Yamamoto T; Sakai H; Kobayashi M; Muro T; Koga M; Shums Z; Norman GL; Ishibashi H
Hepatology; 2007 Jan; 45(1):118-27. PubMed ID: 17187436
[TBL] [Abstract][Full Text] [Related]
27. PBC-AIH overlap syndrome with concomitant ITP and Hashimoto's disease with positivity for anti-centromere antibody.
Arakawa Y; Amaki S; Miyakawa H; Sakai T; Gotou I; Tanaka N; Moriyama M; Iwasaki A; Sugitani M; Arakawa Y
J Gastroenterol; 2004; 39(5):490-5. PubMed ID: 15175950
[TBL] [Abstract][Full Text] [Related]
28. Microchimerism: an investigative frontier in autoimmunity and transplantation.
Adams KM; Nelson JL
JAMA; 2004 Mar; 291(9):1127-31. PubMed ID: 14996783
[TBL] [Abstract][Full Text] [Related]
29. Male microchimerism in women with systemic sclerosis and healthy women who have never given birth to a son.
Lambert NC; Pang JM; Yan Z; Erickson TD; Stevens AM; Furst DE; Nelson JL
Ann Rheum Dis; 2005 Jun; 64(6):845-8. PubMed ID: 15550532
[TBL] [Abstract][Full Text] [Related]
30. [Clinical and pathological analysis on characteristics of primary biliary cirrhosis].
Zhou GD; Zhao JM; Wang SS; Sun YL; Meng EH; Zhang TH; Liu P
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):483-6. PubMed ID: 12939182
[TBL] [Abstract][Full Text] [Related]
31. Evidence of fetal microchimerism in Hashimoto's thyroiditis.
Klintschar M; Schwaiger P; Mannweiler S; Regauer S; Kleiber M
J Clin Endocrinol Metab; 2001 Jun; 86(6):2494-8. PubMed ID: 11397845
[TBL] [Abstract][Full Text] [Related]
32. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis].
Onozuka Y; Shibata M; Yonezawa H; Terauti K; Miyachi K; Ueno Y
Rinsho Byori; 1996 Sep; 44(9):877-82. PubMed ID: 8911074
[TBL] [Abstract][Full Text] [Related]
33. Microchimerism of maternal origin persists into adult life.
Maloney S; Smith A; Furst DE; Myerson D; Rupert K; Evans PC; Nelson JL
J Clin Invest; 1999 Jul; 104(1):41-7. PubMed ID: 10393697
[TBL] [Abstract][Full Text] [Related]
34. [Association of autoimmune disease in primary biliary cirrhosis].
Takagi T; Kasukawa R
Nihon Rinsho; 1994 Jan; 52(1):251-5. PubMed ID: 8114302
[TBL] [Abstract][Full Text] [Related]
35. From the simple detection of microchimerism in patients with autoimmune diseases to its implication in pathogenesis.
Lambert NC; Stevens AM; Tylee TS; Erickson TD; Furst DE; Nelson JL
Ann N Y Acad Sci; 2001 Sep; 945():164-71. PubMed ID: 11708474
[TBL] [Abstract][Full Text] [Related]
36. Lack of evidence of foetal microchimerism in female Spanish patients with systemic sclerosis.
Selva-O'Callaghan A; Mijares-Boeckh-Behrens T; Prades EB; Solans-Laqué R; Simeón-Aznar CP; Fonollosa-Pla V; Vilardell-Tarrés M
Lupus; 2003; 12(1):15-20. PubMed ID: 12587821
[TBL] [Abstract][Full Text] [Related]
37. HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals.
Artlett CM; O'Hanlon TP; Lopez AM; Song YW; Miller FW; Rider LG
Arthritis Rheum; 2003 Sep; 48(9):2567-72. PubMed ID: 13130476
[TBL] [Abstract][Full Text] [Related]
38. Possible role of endogenous retinoid (Vitamin A) toxicity in the pathophysiology of primary biliary cirrhosis.
Erickson JM; Mawson AR
J Theor Biol; 2000 Sep; 206(1):47-54. PubMed ID: 10968936
[TBL] [Abstract][Full Text] [Related]
39. Male microchimerism in women without sons: quantitative assessment and correlation with pregnancy history.
Yan Z; Lambert NC; Guthrie KA; Porter AJ; Loubiere LS; Madeleine MM; Stevens AM; Hermes HM; Nelson JL
Am J Med; 2005 Aug; 118(8):899-906. PubMed ID: 16084184
[TBL] [Abstract][Full Text] [Related]
40. Canals of Hering loss relates to the progression of the histological stages of primary biliary cirrhosis.
Kakuda Y; Harada K; Nakanuma Y
J Clin Pathol; 2015 Feb; 68(2):141-7. PubMed ID: 25430494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
